Pillar Biosciences, oncoReveal Myeloid v2, Next-Generation Sequencing, NGS, Myeloid Malignancies, FLT3-ITD, Acute Myeloid Leukemia, AML, Molecular Diagnostics, Cancer Genomics

Natick, Massachusetts, U.S., October 5, 2026 Pillar Biosciences has launched oncoReveal® Myeloid v2 Panel, an expanded research-use-only (RUO) DNA...